IRWD: 2026 AGM to Elect Directors, Approve Equity Plan Share Increase

Ironwood Pharmaceuticals will hold its 2026 Annual Meeting of Stockholders virtually on June 16, 2026. Stockholders will vote on the election of eight director nominees, an advisory resolution on named executive officer compensation, and the ratification of KPMG LLP as the company's auditors for 2026. A key proposal includes approving an amendment to the 2019 Equity Incentive Plan to increase available shares by 10,000,000. The board recommends voting "for" all proposals.